Microsoft and its Seattle-based neighbor Adaptive Biotechnologies have been in partnership since 2018 on immuno-sequencing advancements. Now, they’re pivoting their work to collaborate on COVID-19 vaccine development.
READ THE STORY at FierceHealthcare »